{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T22:12:27Z","timestamp":1765836747233,"version":"3.48.0"},"reference-count":44,"publisher":"BMJ","issue":"7","license":[{"start":{"date-parts":[[2020,7,5]],"date-time":"2020-07-05T00:00:00Z","timestamp":1593907200000},"content-version":"unspecified","delay-in-days":4,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2020,4,15]]},"published-print":{"date-parts":[[2020,7]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>The first-line recommended treatment for patients with intermittent claudication (IC) is a supervised exercise programme (SEP), which includes a minimum of 2-hours of exercise per week over a 12-week period. However, provision, uptake and adherence rates for these SEP programmes are poor, with time constraints cited as a common participant barrier. High-intensity interval training (HIIT) is more time-efficient and therefore has the potential to overcome this barrier. However, evidence is lacking for the role of HIIT in those with IC. This proof-of-concept study aims to consider the safety, feasibility, tolerability and acceptability of a HIIT programme for patients with IC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>This multicentre, single-group, prospective, interventional feasibility study will recruit 40 patients with IC, who will complete 6 weeks of HIIT, 3 times a week. HIIT will involve a supervised programme of 10\u00d71\u2009min high-intensity cycling intervals at 85%\u201390%\u2009peak power output (PPO), interspaced with 10\u00d71\u2009min low intensity intervals at 20%\u201325% PPO. PPO will be determined from a baseline cardiopulmonary exercise test (CPET) and it is intended that patients will achieve \u226585% of maximum heart rate from CPET, by the end of the second HIIT interval. Primary outcome measures are safety (occurrence of adverse events directly related to the study), programme feasibility (including participant eligibility, recruitment and completion rates) and HIIT tolerability (ability to achieve and maintain the required intensity). Secondary outcomes include patient acceptability, walking distance, CPET cardiorespiratory fitness measures and quality of life outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>Ethical approval was obtained via a local National Health Service research ethics committee (Bradford Leeds \u2013 18\/YH\/0112) and recruitment began in August 2019 and will be completed in October 2020. Results will be published in peer-reviewed journals and presented at international conferences and are expected to inform a future pilot randomised controlled trial of HIIT versus usual-care SEPs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" specific-use=\"clinicaltrial pre-results\" xlink:href=\"NCT04042311\">NCT04042311<\/jats:ext-link>\n                      ; Pre-results.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2020-038825","type":"journal-article","created":{"date-parts":[[2020,7,7]],"date-time":"2020-07-07T06:45:28Z","timestamp":1594104328000},"page":"e038825","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":8,"title":["High INtensity Interval Training In pATiEnts with intermittent claudication (INITIATE): protocol for a multicentre, proof-of-concept, prospective interventional study"],"prefix":"10.1136","volume":"10","clinical-trial-number":[{"clinical-trial-number":"nct04042311","registry":"10.18810\/clinical-trials-gov","type":"preResults"},{"clinical-trial-number":"nct04042311","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1685-2091","authenticated-orcid":false,"given":"Sean","family":"Pymer","sequence":"first","affiliation":[{"name":"Academic Vascular Surgical Unit, Hull York Medical School, Hull, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy","family":"Harwood","sequence":"additional","affiliation":[{"name":"Centre for Sport, Exercise and Life Sciences, Coventry University, Coventry, New South Wales, UK"},{"name":"Department of Sport, Health and Exercise Science, University of Hull, Hull, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9457-7887","authenticated-orcid":false,"given":"Said","family":"Ibeggazene","sequence":"additional","affiliation":[{"name":"Academic Vascular Surgical Unit, Hull York Medical School, Hull, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8963-9107","authenticated-orcid":false,"given":"Gordon","family":"McGregor","sequence":"additional","affiliation":[{"name":"Centre for Sport, Exercise and Life Sciences, Coventry University, Coventry, New South Wales, UK"},{"name":"Department of Cardiac Rehabilitation, Centre for Exercise and Health, University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK"},{"name":"Warwick Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Huang","sequence":"additional","affiliation":[{"name":"Institute of Clinical and Applied Health Research, Hull York Medical School, University of Hull, Hull, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maureen","family":"Twiddy","sequence":"additional","affiliation":[{"name":"Institute of Clinical and Applied Health Research, Hull York Medical School, University of Hull, Hull, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam R","family":"Nicholls","sequence":"additional","affiliation":[{"name":"Department of Sport, Health and Exercise Science, University of Hull, Hull, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lee","family":"Ingle","sequence":"additional","affiliation":[{"name":"Department of Sport, Health and Exercise Science, University of Hull, Hull, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sean","family":"Carroll","sequence":"additional","affiliation":[{"name":"Department of Sport, Health and Exercise Science, University of Hull, Hull, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judith","family":"Long","sequence":"additional","affiliation":[{"name":"Academic Vascular Surgical Unit, Hull York Medical School, Hull, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marjorie","family":"Rooms","sequence":"additional","affiliation":[{"name":"Hull, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I C","family":"Chetter","sequence":"additional","affiliation":[{"name":"Academic Vascular Surgical Unit, Hull York Medical School, Hull, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2020,7,6]]},"reference":[{"key":"2025121514074968000_10.7.e038825.1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200105243442108"},{"key":"2025121514074968000_10.7.e038825.2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.71.3.510"},{"key":"2025121514074968000_10.7.e038825.3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)61249-0"},{"key":"2025121514074968000_10.7.e038825.4","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0002-9149(01)01672-1","article-title":"Intermittent claudication: effective medical management of a common circulatory problem","volume":"87","author":"Beebe","year":"2001","journal-title":"Am J Cardiol"},{"key":"2025121514074968000_10.7.e038825.5","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j5842"},{"key":"2025121514074968000_10.7.e038825.6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199202063260605"},{"key":"2025121514074968000_10.7.e038825.7","doi-asserted-by":"publisher","DOI":"10.1016\/S1078-5884(05)80018-8"},{"key":"2025121514074968000_10.7.e038825.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2005.11.027"},{"key":"2025121514074968000_10.7.e038825.9","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.105.593442"},{"key":"2025121514074968000_10.7.e038825.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2006.12.037"},{"key":"2025121514074968000_10.7.e038825.11","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.116.303849"},{"key":"2025121514074968000_10.7.e038825.12","unstructured":"NICE . Peripheral arterial disease: diagnosis and management. Clinical guidance 147, 2012."},{"key":"2025121514074968000_10.7.e038825.13","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1093\/eurheartj\/ehx095","article-title":"2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for vascular surgery (ESVS) document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries endorsed by: the European stroke organization (ESO) the task force for the diagnosis and treatment of peripheral arterial diseases of the European Society of cardiology (ESC) and of the European Society for vascular surgery (ESVS)","volume":"39","author":"Aboyans","year":"2017","journal-title":"Eur Heart J"},{"key":"2025121514074968000_10.7.e038825.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.11.008"},{"key":"2025121514074968000_10.7.e038825.15","first-page":"CD000990","article-title":"Exercise for intermittent claudication","volume":"12","author":"Lane","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"2025121514074968000_10.7.e038825.16","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.111.075770"},{"key":"2025121514074968000_10.7.e038825.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2014.12.043"},{"key":"2025121514074968000_10.7.e038825.18","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1308\/rcsbull.2017.207","article-title":"Access to supervised exercise services for peripheral vascular disease patients","volume":"99","author":"Harwood","year":"2017","journal-title":"The Bulletin of the Royal College of Surgeons of England"},{"key":"2025121514074968000_10.7.e038825.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.avsg.2016.02.009"},{"key":"2025121514074968000_10.7.e038825.20","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jvn.2017.12.002","article-title":"Preferred exercise modalities in patients with intermittent claudication","volume":"36","author":"Harwood","year":"2018","journal-title":"J Vasc Nurs"},{"key":"2025121514074968000_10.7.e038825.21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/OAJSM.S150596","article-title":"High-Intensity interval training versus moderate-intensity continuous training within cardiac rehabilitation: a systematic review and meta-analysis","volume":"9","author":"Hannan","year":"2018","journal-title":"Open Access J Sports Med"},{"key":"2025121514074968000_10.7.e038825.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.hlc.2015.06.828"},{"key":"2025121514074968000_10.7.e038825.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.hlc.2014.09.001"},{"key":"2025121514074968000_10.7.e038825.24","doi-asserted-by":"publisher","DOI":"10.1136\/bjsports-2013-092576"},{"key":"2025121514074968000_10.7.e038825.25","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1016\/j.jvs.2019.03.050","article-title":"A systematic review of high-intensity interval training as an exercise intervention for intermittent claudication","volume":"70","author":"Pymer","year":"2019","journal-title":"J Vasc Surg"},{"key":"2025121514074968000_10.7.e038825.26","doi-asserted-by":"crossref","unstructured":"Pymer S , Ibeggazene S , Palmer J , et al . A prospective observational cohort study considering the feasibility and tolerability of high intensity interval training as a novel treatment therapy for patients with intermittent claudication. medRxiv 2020.","DOI":"10.1101\/2020.04.01.20049569"},{"key":"2025121514074968000_10.7.e038825.27","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e7586"},{"key":"2025121514074968000_10.7.e038825.28","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-158-3-201302050-00583"},{"key":"2025121514074968000_10.7.e038825.29","unstructured":"ACSM . ACSM's guidelines for exercise testing and prescription. 9th ed. Baltimore: Lippincott, Williams, & Wilkins, 2014."},{"key":"2025121514074968000_10.7.e038825.30","doi-asserted-by":"crossref","first-page":"402???408","DOI":"10.1249\/00005768-199104000-00003","article-title":"Progressive vs single-stage treadmill tests for evaluation of claudication","volume":"23","author":"Gardner","year":"1991","journal-title":"Med Sci Sports Exerc"},{"key":"2025121514074968000_10.7.e038825.31","doi-asserted-by":"publisher","DOI":"10.1067\/mva.2001.112326"},{"key":"2025121514074968000_10.7.e038825.32","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.305.6846.160"},{"key":"2025121514074968000_10.7.e038825.33","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-012843"},{"key":"2025121514074968000_10.7.e038825.34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2005.05.049"},{"key":"2025121514074968000_10.7.e038825.35","unstructured":"Tew GA , Harwood AE , Ingle L , et al . The bases expert statement on exercise training for people with intermittent claudication due to peripheral arterial disease. The Sport and Exercise Scientist 2018."},{"key":"2025121514074968000_10.7.e038825.36","doi-asserted-by":"publisher","DOI":"10.1016\/j.avsg.2012.05.005"},{"key":"2025121514074968000_10.7.e038825.37","doi-asserted-by":"publisher","DOI":"10.1046\/j.1475-097X.2002.00442.x"},{"key":"2025121514074968000_10.7.e038825.38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2007.09.001"},{"key":"2025121514074968000_10.7.e038825.39","doi-asserted-by":"publisher","DOI":"10.1016\/S1078-5884(97)80070-6"},{"key":"2025121514074968000_10.7.e038825.40","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0b013e3181e52e69"},{"key":"2025121514074968000_10.7.e038825.41","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0b013e31829b5b44"},{"key":"2025121514074968000_10.7.e038825.42","doi-asserted-by":"crossref","first-page":"281","DOI":"10.12968\/hmed.2015.76.5.281","article-title":"A clinician's guide to cardiopulmonary exercise testing 2: test interpretation","volume":"76","author":"Nichols","year":"2015","journal-title":"Br J Hosp Med"},{"key":"2025121514074968000_10.7.e038825.43","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i5239"},{"key":"2025121514074968000_10.7.e038825.44","doi-asserted-by":"publisher","DOI":"10.1191\/1478088706qp063oa"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2020-038825","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T22:07:59Z","timestamp":1765836479000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2020-038825"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":44,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2020,7,6]]},"published-print":{"date-parts":[[2020,7]]}},"alternative-id":["10.1136\/bmjopen-2020-038825"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2020-038825","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"type":"print","value":"2044-6055"},{"type":"electronic","value":"2044-6055"}],"subject":[],"published":{"date-parts":[[2020,7]]}}}